№7 / 2019

REVIEWS
T.Yu. Semiglazova (1, 2), I.V. Sorokina (3)
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer
10-20
A.E. Zhukova, S.A. Protsenko, A.V. Novik, D.O. Yurlov
Prognostic markers for testicular germ cell tumors. Research perspectives
21-26
I.A. Baldueva (1), A.V. Novik (1, 2)
The role of peripheral blood immunological parameters as predictive markers in cancer patients: the prognostic role of the neutrophil/lymphocyte ratio
28-32
ORIGINAL ARTICLES
N.N. Buevich (1), S.A. Protsenko (1), A.K. Nosov (1), S.A. Reva (1, 2), A.S. Artemyeva (1), M.V. Berkut (1)
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
33-37
N.P. Belyak (1, 2), S.I. Kutukova (1, 3), R.V. Orlova (1, 2), N.V. Zhukova (1, 2), S.P. Erdniev (1), E.Yu. Zorina (1), I.V. Avramenko (1), N.Yu. Antimonik (1), N.V. Popova (1), A.K. Ivanova (1), A.V. Androsova (1)
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
38-42
E.V. Bakhidze (1, 2), V.A. Belyaeva (3), A.A. Domansky (1), N.A. Mikaya (1), I.V. Berlev (1, 2)
Pharmacotherapy and surgical treatment of adult granulosa cell ovarian tumors: analysis of own and literature data
43-49
P.V. Kazantseva (1), E.M. Slonimskaya (1, 2), M.M. Tsyganov (1), M.K. Ibragimova (1, 3), A.V. Doroshenko (1), N.A. Tarabanovskaya (1), N.V. Litviakov (1, 3)
Predictive and prognostic significance of stemness gene amplifications in the breast tumor in patients who received neoadjuvant chemotherapy
50-56
L.Yu. Vladimirova, I.L. Popova, N.A. Abramova, A.E. Storozhakova, N.M. Tikhanovskaya, K.A. Novoselova, A.A. Lyanova, L.A. Ryadinskaya, M.O. Yezhova, M.A. Teplyakov
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis
58-63
L.V. Filatova (1, 2)
Immunotherapy for classic Hodgkin’s lymphoma
64-72
S.A. Protsenko (1), A.I. Semenova (1), A.P. Oganesyan (1), E.M. Anokhina (1), A.V. Novik (1, 2)
Modern immunotherapy for kidney cancer
73-78
K.O. Kondratieva, M.V. Vagaytseva, T.Yu. Semiglazova
The role of the medical psychologist in the multidisciplinary team for the rehabilitation of cancer patients
79-81
V.S. Fomin, V.N. Yakovenko
Resonance electrostimulation in the treatment of postoperative motor-evacuation disorders: theoretical rationale and therapeutic algorithm of application
82-87
N.V. Zhukova (1, 2), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1, 2), O.V. Vasyusina (3), N.V. Popova (1)
The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions: clinical observation
88-95
D.D. Sakaeva (1, 2), A.F. Nasretdinov (1)
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice
96-101
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience
102-107

Бионика Медиа